RPRX - Royalty Pharma plc
47.48
0.010 0.021%
Share volume: 3,681,476
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$47.47
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-06-2024 | 02-12-2025 | 05-08-2025 | 11-05-2025 | 02-11-2026 | |
| Assets | ||||||||
| Total Assets | 16.131 B | 17.657 B | 18.042 B | 18.223 B | 17.608 B | 19.347 B | 19.621 B | |
| Current Assets | 1.560 B | 2.579 B | 1.794 B | 1.802 B | 1.843 B | 1.850 B | 1.528 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 665.492 M | 25.872 M | 29.870 M | 31.143 M | 26.864 M | 34.420 M | 36.209 M | |
| Short Term Investments | 665.492 M | 38.500 M | 48.500 M | 58.200 M | 12.100 M | 16.100 M | 18.800 M | |
| Total Receivables | 22.227 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 872.000 M | 1.765 B | 950.052 M | 929.026 M | 1.088 B | 938.944 M | 618.696 M | |
| Total Non-current Assets | 14.571 B | 981.999 M | 1.008 B | 1.073 B | 555.208 M | 593.457 M | 708.968 M | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 13.470 B | 15.077 B | 16.248 B | 16.421 B | 15.765 B | 17.498 B | 18.093 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 16.131 B | 17.657 B | 18.042 B | 18.223 B | 17.608 B | 19.347 B | 19.621 B | |
| Total liabilities | 9.631 B | 7.905 B | 7.784 B | 7.880 B | 7.820 B | 9.726 B | 9.906 B | |
| Total current liabilities | 124.574 M | 275.701 M | 1.168 B | 1.254 B | 1.183 B | 530.802 M | 636.211 M | |
| Accounts Payable | 0.000 | 23.416 M | 22.055 M | 13.370 M | 37.630 M | 41.415 M | 19.404 M | |
| Other liabilities | 3.220 M | 27.041 M | 5.580 M | 12.080 M | 17.900 M | 629.882 M | 698.713 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 6.139 B | 7.602 B | 6.610 B | 6.615 B | 6.619 B | 8.566 B | 8.571 B | |
| Other liabilities | 3.220 M | 27.041 M | 5.580 M | 12.080 M | 17.900 M | 629.882 M | 698.713 M | |
| Minority interest | 3.364 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.500 B | 6.476 B | 6.870 B | 6.947 B | 6.689 B | 6.414 B | 6.477 B | |
| Common stock | 448.623 M | 4.101 B | 4.108 B | 4.104 B | 4.211 B | 4.113 B | 4.123 B | |
| Retained earnings | 2.427 B | 2.378 B | 2.765 B | 2.846 B | 2.481 B | 2.304 B | 2.356 B |